121988

Source:http://linkedlifedata.com/resource/pubmed/id/121988

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006796, umls-concept:C0038463, umls-concept:C0087111, umls-concept:C0439861
pubmed:issue	3-4
pubmed:dateCreated	1981-3-24
pubmed:abstractText	The Author studied the therapeutic activity of a new drug - Cambendazole, in the treatment of 100 children suffering from strongyloidiasis infection. The patients received a single dose of the 5 mg per K of body weight, and laboratorial controls were made in the 7th, 8th, 9th, and 10th after the treatment and consisting of Berman-Moraes method.
pubmed:language	por
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374633
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Cambendazole
pubmed:status	MEDLINE
pubmed:issn	0016-3503
pubmed:author	pubmed-author:HugginsDD
pubmed:issnType	Print
pubmed:volume	33
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	301-5
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:121988-Benzimidazoles, pubmed-meshheading:121988-Cambendazole, pubmed-meshheading:121988-Child, pubmed-meshheading:121988-Child, Preschool, pubmed-meshheading:121988-Drug Evaluation, pubmed-meshheading:121988-Female, pubmed-meshheading:121988-Humans, pubmed-meshheading:121988-Strongyloidiasis
pubmed:articleTitle	[Cambendazole - a new substance for the treatment of strongyloidiasis].
pubmed:publicationType	Journal Article, English Abstract